Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)
Citron exposes explosive findings behind the true components of Questcor Pharmaceuticals Inc (NASDAQ:QCOR) flagship drug HP Acthar Gel. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) stock performance was -9.96% in last session and finished the day at $60.75. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 2.86 million shares. The beta of the stock remained 0.95. Questcor Pharmaceuticals Inc. … Continue reading Biotech Bearish Stocks: Questcor Pharmaceuticals (NASDAQ:QCOR), ACADIA Pharmaceuticals (NASDAQ:ACAD), Idera Pharmaceuticals (NASDAQ:IDRA), Celldex Therapeutics (NASDAQ:CLDX)
Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Rexahn Pharmaceuticals (NYSEMKT:RNN), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)
ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -3.34% in last session and finished the day at $8.69. Traded volume was 1,200.00 shares in the last session and the average volume of the stock remained 26.48 million shares. The beta of the stock remained 1.64. Ariad Pharmaceuticals, Inc. … Continue reading Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Rexahn Pharmaceuticals (NYSEMKT:RNN), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)
Monday Morning Roundup: AstraZeneca plc (NYSE:AZN), Rockwood Holdings (NYSE:ROC), The Men’s Wearhouse (NYSE:MW)
The American Depositary Receipts of AstraZeneca plc (NYSE:AZN) slipped nearly 2% in Monday’s pre-market session after the drugmaker reported that the U.S. FDA approved its Bydureon Pen (2 mg) despite a boxed warning regarding the risk of thyroid C-cell tumors in the use of Bydureon. The Bydureon Pen is an injectable suspension used as a supplement to diet and exercise for patients with Type 2 … Continue reading Monday Morning Roundup: AstraZeneca plc (NYSE:AZN), Rockwood Holdings (NYSE:ROC), The Men’s Wearhouse (NYSE:MW)
Tyco (NYSE:TYC) Selling Korea Unit to Carlyle Group for $1.93
Tyco (NYSE:TYC) signed a definitive agreement to sell Tyco Fire & Security Services Korea Co. Ltd. and its subsidiaries (ADT Caps Co., Ltd., Capstec Co., Ltd. and ADT Security Co., Ltd.) that form and operate the company’s South Korean security business (ADT Korea) to The Carlyle Group (CG), in a cash transaction valued at approximately $1.93 billion. The transaction is expected to close in Tyco’s … Continue reading Tyco (NYSE:TYC) Selling Korea Unit to Carlyle Group for $1.93
Stock in Action: Facebook (NASDAQ FB) Stock Report: Q4 Reactions and More
Facebook (NASDAQ FB) has been going from strength to strength. The biggest social networking site of the world is increasing its user base which is already more than a billion. Despite recent reports of a slowdown in the growth of the number of users, Facebook has indeed posted a great earnings and revenue report for the last financial quarter. Facebook FB Stock has certainly done … Continue reading Stock in Action: Facebook (NASDAQ FB) Stock Report: Q4 Reactions and More
Stock in News: A Look At the Potential of Apple (NASDAQ AAPL) Stock
Apple has been phenomenal in the past few months. After touching a record high at the start of this year, the AAPL stock has been rallying around the levels of $125. Despite such high levels, various analysts have been pinning Apple to perform well and reach even higher levels. In fact, the belief in the market is such that Apple stock is a must have … Continue reading Stock in News: A Look At the Potential of Apple (NASDAQ AAPL) Stock